Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks
A post-authorization safety study evaluating the Euforvac-Hib vaccine for active primary immunization in infants starting at 6 weeks to moni…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years [Phase 1]
Phase 1 safety and dose-ranging study of acellular pertussis vaccine and an acellular pertussis-tetanus-diphtheria booster vaccine in health…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants [Phase 2]
Phase 2 trial of GSK2202083A vaccine in healthy infants completed; multiple conditions tested including tetanus, hepatitis B, Hib, polio, ac…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial assessing safety and immunogenicity of booster doses for new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (GSK217744) in chi…
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Pertussis Vaccine in Healthy Pregnant Women [Phase 1]
Phase 1 trial evaluating a pertussis-containing vaccine in healthy pregnant women has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants [Phase 3]
A Phase 3 trial assessed the booster effect of the DTaP-IPV-HepB-PRP-T vaccine (Infanrix Hexa) and Prevenar in healthy infants; results were…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject [Phase 3]
A Phase 3 clinical trial comparing the immunogenicity and safety of Quinvaxem vaccine given in mono-dose vials versus Uniject.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial update on safety and immunogenicity of new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (DTPa-HBV-IPV/Hib, GSK217744).
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants [Phase 3]
A Phase 3 lot-consistency study of the DTaP-IPV-HB-PRP~T vaccine administered at 2-4-6 months in healthy infants has completed; results were…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants [Phase 3]
Phase 3 study evaluating the DTaP-IPV-Hep B-PRP-T vaccine given with Prevenar and Rotarix in healthy Latin American infants; results were po…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers [Phase 3]
Phase 3 safety trial of Infanrix-IPV+Hib vaccine in healthy Vietnamese toddlers completed with results posted
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose [Phase 4]
This Phase 4 study reports immune responses in adults after revaccination with ADACEL (diphtheria, tetanus, and acellular pertussis) vaccine…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China [Phase 1]
Phase 1 study evaluating the ADACEL Tdap booster in healthy adults and children in China has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants [Phase 3]
Phase 3 trial comparing DTaP-IPV-Hep B-PRP~T Combined Vaccine with Infanrix Hexa in healthy Peruvian infants; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents [Phase 1, Phase 2]
Clinical trial update for the ADACEL booster vaccine in adolescents (Phase 1/Phase 2) with results posted in 2014, evaluating safety and imm…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Immunogenicity and Safety of an Acellular DPT Vaccine During Pregnancy [Phase 2]
Phase 2 study assessing the immunogenicity and safety of an acellular DPT vaccine administered during pregnancy has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® [Phase 2]
Phase 2 study evaluating PR5I, a pediatric combination vaccine with an enhanced Hepatitis B component, given concomitantly with Prevnar; the…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine
Post-marketing safety study of Boostrix vaccine has completed and summarizes safety monitoring for diphtheria, tetanus, and pertussis indica…
-
CLINICAL_TRIALS safety_alert · 2014-01-13Clinical Trial Update: Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine
This is a completed post-marketing safety study of GlaxoSmithKline's Pediarix vaccine, a DTaP-HepB-IPV combination, evaluating safety for He…
-
EMA withdrawal · 2014-01-07EMA Lapsed: Tritanrix HepB (Diphtheria toxoid;hepatitis B surface antigen;Bordetella pertussis (inactivated);tetanus toxoid) — GlaxoSmithKline Biologicals S.A.
EMA status shows the Tritanrix HepB vaccine has lapsed and is no longer an active medicinal product in the EU.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine [Phase 3]
A Phase 3 trial comparing the DTaP-HB-PRP-T combined vaccine to Tritanrix-HepB/Hib, both given concomitantly with oral polio vaccine; result…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants [Phase 2]
Phase 2 trial comparing a DTaP-IPV-Hep B-PRP~T combined vaccine with PENTAXIM and ENGERIX B in Argentinean infants has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™ [Phase 3]
Phase 3 immunogenicity study assessing antibody persistence and booster effects of the DTaP-HB-PRP~T combined vaccine (Tritanrix-HepB/Hib) d…
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants [Phase 3]
Phase 3 immunogenicity update evaluating antibody persistence and booster response of the DTaP-HB PRP-T combination vaccine in Filipino infa…
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants [Phase 3]
Phase 3 trial comparing DTaP-HB-PRP~T with Tritanrix HepB/Hib, administered concomitantly with OPV in healthy infants; results have been pos…